跳至主要内容
临床试验/EUCTR2007-004716-31-NL
EUCTR2007-004716-31-NL进行中(未招募)1 期

Effects of growth hormone treatment after final height in Prader-Willi Syndrome: A double-blind multicenter, cross-over study on the effects of growth hormone versus placebo on body composition and psychosocial behaviour in transition - Effects of GH after final height in PWS

Dutch Growth Foundation0 个研究点开始时间: 2007年11月6日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Genetically confirmed diagnosis of PWS and
  • -treated with GH during childhood for at least 2 years and
  • -final height is reached or epiphysial fusion is complete and
  • -aged 18-24
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -non cooperative behaviour
  • -extremely low dietary intake of less than minimal required intake according to WHO
  • -medication to reduce weight (fat)

研究者

发起方
Dutch Growth Foundation

相似试验